Law Offices of Thomas J. Lamb

  • About Our Firm
  • Drug Injury
  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Breast Implants
  • Free Case Evaluation
  • FAQs

Telomerase reverse transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup

September 1, 2020 By Law Offices of Thomas J. Lamb, P.A.

Purpose: Human malignant pleural mesothelioma (MPM) is characterized by dismal prognosis. Consequently, dissection of molecular mechanisms driving malignancy is of key importance. Here we investigate, whether activating mutations in the telomerase reverse transcriptase (TERT) gene promoter are present in [malignant pleural mesothelioma (MPM)] and … [Read more...]

Filed Under: Mesothelioma Tagged With: mesothelioma, pleural mesothelioma

Malignant Diffuse Mesothelioma in Women — A Study of 354 Cases

February 11, 2020 By Law Offices of Thomas J. Lamb, P.A.

We reviewed 354 cases of malignant diffuse mesothelioma (MM) in women from a database of 2858 histologically confirmed MM cases. There was a pleural predominance with 78% [ pleural malignant mesothelioma ] and 22% [ peritoneal malignant mesothelioma ]. The pleural tumors consisted of 72% epithelioid, 19% biphasic, and 9% sarcomatoid variant. The … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, asbestos exposure, mesothelioma, peritoneal mesothelioma, pleural mesothelioma

50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience

December 27, 2019 By Law Offices of Thomas J. Lamb, P.A.

Background:  The most common sites of malignant mesothelioma are the pleura and peritoneum, but little is known about the incidence, prognosis, or treatment of patients with disease in both cavities. Previous series suggest that multimodality treatment improves overall survival for pleural or peritoneal disease, but studies typically exclude [ … [Read more...]

Filed Under: Mesothelioma Tagged With: mesothelioma, mesothelioma treatments, peritoneal mesothelioma, pleural mesothelioma

Radical hemithoracic radiotherapy doubles survival among certain patients with mesothelioma

December 3, 2019 By Law Offices of Thomas J. Lamb, P.A.

Patients with malignant pleural mesothelioma who underwent nonradical surgery and chemotherapy appeared twice as likely to achieve 2-year OS with radical hemithoracic radiotherapy vs. palliative radiotherapy, according to randomized phase 3 study results presented at European Society for Radiotherapy and Oncology Congress. Based on these … [Read more...]

Filed Under: Mesothelioma Tagged With: mesothelioma, mesothelioma treatments, pleural mesothelioma

Diagnostic Value of Biopsy Sampling in Predicting Histology in Patients With Diffuse Malignant Pleural Mesothelioma

August 15, 2019 By Law Offices of Thomas J. Lamb, P.A.

BACKGROUND: The classification of diffuse malignant mesothelioma into epithelioid, biphasic, and sarcomatoid types is based on histologic patterns. The diagnosis is made on biopsies, and because of intratumoral heterogeneity, they may not be representative of the entire tumor. The number and volume of biopsies needed to reach diagnostic accuracy in … [Read more...]

Filed Under: Mesothelioma Tagged With: malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma diagnosis, pleural mesothelioma

Another Antiangiogenic Failure in Unresectable Mesothelioma

June 20, 2019 By Law Offices of Thomas J. Lamb, P.A.

The addition of nintedanib (Ofev) to standard of care pemetrexed (Alimta) plus cisplatin failed to delay disease progression in patients with unresectable malignant pleural mesothelioma, according to phase III results of the LUME-Meso study. After a median treatment duration of more than 5 months, median progression-free survival was 6.8 months … [Read more...]

Filed Under: Mesothelioma Tagged With: malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments, pleural mesothelioma

50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience

May 13, 2019 By Law Offices of Thomas J. Lamb, P.A.

Background:  The most common sites of malignant mesothelioma are the pleura [ i.e., pleural mesothelioma ] and peritoneum [ i.e., peritoneal mesothelioma ], but little is known about the incidence, prognosis, or treatment of patients with disease in both cavities…. Despite limitations, this investigation is the only study to broadly examine … [Read more...]

Filed Under: Mesothelioma Tagged With: asbestos cancer, mesothelioma, peritoneal mesothelioma, pleural mesothelioma

Current treatments and trials in malignant pleural mesothelioma

August 2, 2018 By Law Offices of Thomas J. Lamb, P.A.

Objectives This article aims to review the evidence from recent clinical trials in mesothelioma, and to provide an overview of relevant clinical trials that are currently in progress. Results Since the original trial that demonstrated the efficacy of pemetrexed and cisplatin in mesothelioma, multiple trials have been conducted that have … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments, pleural mesothelioma

Novel therapies for malignant pleural mesothelioma

March 5, 2018 By Law Offices of Thomas J. Lamb, P.A.

Malignant pleural mesothelioma is a rare cancer that is typically associated with exposure to asbestos. Patients with malignant pleural mesothelioma have poor outcomes with suboptimal therapeutic options and currently no treatment is curative. The standard frontline treatment, cisplatin plus pemetrexed chemotherapy, has only short and insufficient … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments, pleural mesothelioma

Management of Malignant Pleural Mesothelioma: Current Treatment Guidelines

January 22, 2018 By Law Offices of Thomas J. Lamb, P.A.

Purpose: To provide evidence-based recommendations to practicing physicians and others on the management of malignant pleural mesothelioma. Methods: ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, pathology, imaging, and advocacy experts to conduct a literature search, which included systematic … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, mesothelioma, mesothelioma treatments, pleural mesothelioma

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • Drug Injury Cases
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • GenX Cancer Cases
  • Breast Implant Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • About Our Firm
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2021 · Law Offices of Thomas J. Lamb, P.A.